55 Days
Source:
الاقتصادية
Source: الاقتصادية
55 Daysالاقتصادية
Source: الاقتصادية
55 DaysReady to play
Ready to play
Sarat Ventures Fund aims to invest in biotechnology in Saudi Arabia, allocating around $100 million to approximately 15 to 20 advanced companies in terms of growth, manufacturing, and revenue generation, with annual revenues reaching up to $2 million. The goal is to support companies capable of achieving commercial operations and selling their products independently. The fund focuses on companies that have reached at least Series A financing or higher, with potential for reinvestment after five years to increase the portfolio size by fivefold. It is expected that the biotechnology market in Saudi Arabia will reach $150 billion by 2030, with an annual growth rate estimated at 13.5%.
Notice: This Is an AI-Generated Summary
Comments (0)